Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 4.300
-0.860 (-16.67%)
May 28, 2026, 3:13 PM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 1 billion as of May 28, 2026. Its market cap has increased by 14.67% in one year.
Market Cap
1.00B
Enterprise Value
1.03B
Revenue
74.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.30
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 1.00B, a decrease of -67.61%. That is a compound annual growth rate of -34.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 833.55M | -46.38% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.45B |
| Zhaoke Ophthalmology | 1.40B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.40B |
| Kintor Pharmaceutical | 1.22B |
| CANbridge Pharmaceuticals | 1.06B |
| Sunho Biologics | 970.43M |
| 3D Medicines | 866.21M |
| Brii Biosciences | 830.08M |